Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.

Hayashi H, Ruggeri A, Volt F, Cornelissen JJ, Socié G, Sengeloev H, Michallet M, Karakasis D, Petersen E, Cahn JY, Veelken H, Mercier M, Rohrlich PS, Rafii H, Kenzey C, Xavier E, Duarte RF, Basak GW, Rocha V, Gluckman E; Eurocord and the Complications and Quality of Life WP of EBMT.

Bone Marrow Transplant. 2018 Apr;53(4):417-421. doi: 10.1038/s41409-017-0061-9. Epub 2018 Jan 12. No abstract available.

PMID:
29330402
2.

Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.

Moon JH, Sohn SK, Lambie A, Ellis L, Hamad N, Uhm J, Gupta V, Lipton JH, Messner HA, Kuruvilla J, Kim D.

Biol Blood Marrow Transplant. 2014 Apr;20(4):556-63. doi: 10.1016/j.bbmt.2014.01.010. Epub 2014 Jan 18.

3.

Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.

Inagaki J, Moritake H, Nishikawa T, Hyakuna N, Okada M, Suenobu S, Nagai K, Honda Y, Shimomura M, Fukano R, Noguchi M, Kurauchi K, Tanioka S, Okamura J.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1973-80. doi: 10.1016/j.bbmt.2015.07.025. Epub 2015 Jul 31.

4.

Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.

Sato T, Ichinohe T, Kanda J, Yamashita K, Kondo T, Ishikawa T, Uchiyama T, Takaori-Kondo A.

Int J Hematol. 2011 Apr;93(4):532-541. doi: 10.1007/s12185-011-0820-0. Epub 2011 Apr 5.

PMID:
21465116
5.

Oral manifestations compatible with chronic graft-versus-host disease in patients with Fanconi anemia.

Grein Cavalcanti L, Fuentes Araújo RL, Bonfim C, Torres-Pereira CC.

Biol Blood Marrow Transplant. 2015 Feb;21(2):275-80. doi: 10.1016/j.bbmt.2014.10.009. Epub 2014 Oct 12.

6.

National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.

Baird K, Steinberg SM, Grkovic L, Pulanic D, Cowen EW, Mitchell SA, Williams KM, Datiles MB, Bishop R, Bassim CW, Mays JW, Edwards D, Cole K, Avila DN, Taylor T, Urban A, Joe GO, Comis LE, Berger A, Stratton P, Zhang D, Shelhamer JH, Gea-Banacloche JC, Sportes C, Fowler DH, Gress RE, Pavletic SZ.

Biol Blood Marrow Transplant. 2013 Apr;19(4):632-9. doi: 10.1016/j.bbmt.2013.01.013. Epub 2013 Jan 20.

7.

Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.

Del Fante C, Scudeller L, Viarengo G, Bernasconi P, Perotti C.

Transfusion. 2012 Sep;52(9):2007-15. doi: 10.1111/j.1537-2995.2011.03542.x. Epub 2012 Feb 10.

PMID:
22320219
8.

Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.

Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1781-1791. doi: 10.1016/j.bbmt.2016.06.020. Epub 2016 Jun 22.

9.

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers ME, Cowen EW, Schubert M, Turner ML, Lee SJ, Martin P, Bishop MR, Baird K, Bolaños-Meade J, Boyd K, Fall-Dickson JM, Gerber LH, Guadagnini JP, Imanguli M, Krumlauf MC, Lawley L, Li L, Reeve BB, Clayton JA, Vogelsang GB, Pavletic SZ.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1619-29. doi: 10.1016/j.bbmt.2011.04.002. Epub 2011 Apr 12.

10.

Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.

Aki SZ, Inamoto Y, Carpenter PA, Storer BE, Sandmaier BM, Lee SJ, Martin PJ, Flowers ME.

Bone Marrow Transplant. 2016 Oct;51(10):1350-1353. doi: 10.1038/bmt.2016.131. Epub 2016 May 23.

11.

Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.

Jagasia M, Giglia J, Chinratanalab W, Dixon S, Chen H, Frangoul H, Engelhardt B, Goodman S, Greer J, Kassim A, Morgan D, Ruffner K, Schuening F.

Biol Blood Marrow Transplant. 2007 Oct;13(10):1207-15. Epub 2007 Aug 24.

12.

Histopathologic diagnosis of chronic graft-versus-host disease of the oral mucosa according to the National Institutes of Health Consensus.

Santos PS, Coracin FL, Barros JC, Gallottini MH.

Einstein (Sao Paulo). 2014 Apr;12(2):204-10. English, Portuguese.

13.

Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease.

Aisa Y, Mori T, Kato J, Yamane A, Kohashi S, Kikuchi T, Okamoto S.

Int J Hematol. 2013 Feb;97(2):263-71. doi: 10.1007/s12185-013-1268-1. Epub 2013 Feb 1.

PMID:
23371545
14.

Feasibility of NIH consensus criteria for chronic graft-versus-host disease.

Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim DW, Lee JW, Min WS, Kim CC.

Leukemia. 2009 Jan;23(1):78-84. doi: 10.1038/leu.2008.276. Epub 2008 Oct 2.

PMID:
18830253
15.

The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification.

Socié G.

Leukemia. 2009 Jan;23(1):1-2. doi: 10.1038/leu.2008.277. No abstract available.

PMID:
19142188
16.

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality.

Pidala J, Kim J, Anasetti C, Nishihori T, Betts B, Field T, Perkins J.

Haematologica. 2011 Nov;96(11):1678-84. doi: 10.3324/haematol.2011.049841. Epub 2011 Jul 26.

17.

Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.

Greinix HT, Loddenkemper C, Pavletic SZ, Holler E, Socié G, Lawitschka A, Halter J, Wolff D.

Biol Blood Marrow Transplant. 2011 Feb;17(2):167-75. doi: 10.1016/j.bbmt.2010.07.017. Epub 2010 Aug 5.

18.

Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.

Kim DY, Lee JH, Lee JH, Kim SH, Lim SN, Kim SD, Choi Y, Lee YS, Kang YA, Kang SI, Seol M, Ryu SG, Lee KH.

Bone Marrow Transplant. 2010 Jul;45(7):1174-80. doi: 10.1038/bmt.2009.320. Epub 2009 Nov 16.

PMID:
19915630
19.

Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.

Gutman JA, Ross K, Smith C, Myint H, Lee CK, Salit R, Milano F, Delaney C, Gao D, Pollyea DA.

Bone Marrow Transplant. 2016 Dec;51(12):1588-1593. doi: 10.1038/bmt.2016.186. Epub 2016 Jul 11.

PMID:
27400068
20.

Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD.

Blecha C, Wolff D, Holler B, Holler E, Weber D, Vogt R, Helbig H, Dietrich-Ntoukas T.

Ann Hematol. 2016 Feb;95(3):493-9. doi: 10.1007/s00277-015-2575-9. Epub 2015 Dec 14.

PMID:
26659079

Supplemental Content

Support Center